Jeffrey W. Albers serves as Executive at Blueprint Medicines Corp, where they oversee executive responsibilities. Since joining the company, Jeffrey W. Albers has executed 213 insider transactions totaling $58.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 7, 2017 involved selling 2,786 shares valued at $134.5K.
Jeffrey W. Albers currently holds 5,000 shares of Blueprint Medicines Corp (BPMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey W. Albers has been a net seller of BPMC stock. They have purchased $0 and sold $58.2M worth of shares.
Jeffrey W. Albers's most recent insider trade was on Aug 7, 2017, when they sold 2,786 shares at $48.29 per share.
Get notified when new Form 4 filings are submitted
| $49.21 |
| Discretionary |
| Jun 28, 2017 | BPMC | $109.4K | Sale | 2,229 | $49.10 | Discretionary |
| Jun 28, 2017 | BPMC | $512.5K | Sale | 10,205 | $50.22 | Discretionary |
| Jun 28, 2017 | BPMC | $387.5K | Sale | 7,566 | $51.21 | Discretionary |
| Mar 14, 2017 | BPMC | $39.0K | Sale | 980 | $39.75 | Discretionary |
| Mar 14, 2017 | BPMC | $761.6K | Sale | 19,020 | $40.04 | Discretionary |
| Aug 8, 2016 | BPMC | $23.4K | Sale | 1,008 | $23.22 | Discretionary |
| Aug 8, 2016 | BPMC | $365.3K | Sale | 15,992 | $22.84 | Discretionary |
| Jun 3, 2016 | BPMC | $340.5K | Sale | 17,000 | $20.03 | Discretionary |
| Apr 6, 2016 | BPMC | $347.1K | Sale | 17,000 | $20.42 | Discretionary |
| Nov 10, 2015 | BPMC | $153.1K | Sale | 7,000 | $21.87 | Discretionary |
| Nov 2, 2015 | BPMC | $210.2K | Sale | 10,000 | $21.02 | Discretionary |